FormWeb • quiNINE

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Add Formweb to your mobile device

Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

quiNINE

quiNINE

Restricted Limited to use for treatment of malaria
Restricted Miscellaneous Program Formulary

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Qualaquin	CAPSULE, ORAL	324 mg

Comments:

Qualaquin medication guide

In response to the FDA safety alert, the P&T Committee has approved restriction of quiNINE to the treatment of malaria. If ordered for off label uses, the physician and patient should be informed of the FDA statement and encouraged not to use in the hospital. After a period of education, quiNINE use will be limited to malaria use only.

Reviewed: March 27, 2007

Last updated: Aug. 21, 2017

Black Box Warning: No benefit in leg cramps; hematologic risks

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.